P3 Health Partners Inc (PIII)

Currency in USD
12.8300
+1.2500(+10.79%)
Closed·
16.2113+3.3813(+26.35%)
·
Unusual Post-Market activity
Earnings results expected today
PIII is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.730013.8192
52 wk Range
1.520016.8900
Key Statistics
Prev. Close
11.58
Open
11.73
Day's Range
11.73-13.8192
52 wk Range
1.52-16.89
Volume
73.46K
Average Volume (3m)
1.27M
1-Year Change
91.4925%
Book Value / Share
-43.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PIII Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.0000
Upside
+9.12%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

P3 Health Partners Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.0000
(+9.12% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Hold14.00+9.12%3.00MaintainMay 22, 2026
Lake Street
Buy14.00+9.12%4.00MaintainMay 15, 2026
TD Cowen
Hold3.00-76.62%8.00MaintainApr 02, 2026
Lake Street
Buy4.00-68.82%12.50MaintainMar 27, 2026
Lake Street Capital Markets
Buy12.50-2.57%20.00MaintainNov 17, 2025

P3 Health Partners Inc Earnings Call Summary for Q2/2026

  • P3 Health Partners reported Q2 2026 adjusted loss of $0.63/share vs. consensus $2.01, beating by $1.38; revenue rose 8.4% to $386.3M vs. $375.05M estimate.
  • Adjusted EBITDA swung to $54M profit from $17M loss year-ago, aided by $41M payer settlements; company raised FY2026 EBITDA guidance to $80M-$110M.
  • Medical cost trend ran 1.8% below 2025 baseline vs. 5-7% peer inflation; management claims core operations now generate positive EBITDA excluding one-time items.
  • At-risk membership declined to 105K from 116K year-ago; company holds just $21M cash with 0.33 current ratio, raising liquidity concerns per InvestingPro.
  • Shares surged 24.71% after-hours to $16; management expects $15M additional H2 EBITDA but warns of seasonal medical cost pressures and uncertain 2027 pricing.
Last Updated: 2026-08-10, 05:14 p/m
Read Full Transcript

Earnings

Latest Release
Aug 10, 2026
EPS / Forecast
-0.63 / -2.01
Revenue / Forecast
386.3M / 375.05M
EPS Revisions
Last 90 days

PIII Income Statement

Compare PIII to Peers and Sector

Metrics to compare
PIII
Peers
Sector
Relationship
P/E Ratio
−0.7x−0.2x−0.4x
PEG Ratio
−0.010.010.00
Price/Book
−0.6x2.9x2.6x
Price / LTM Sales
0.1x0.3x3.1x
Upside (Analyst Target)
20.9%16.6%48.5%
Fair Value Upside
Unlock39.1%5.8%Unlock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
63.49K1.91%735.26K
Other Institutional Investors
2.29M68.71%26.46M
Public Companies & Retail Investors
977.27K29.38%11.32M
Total
3.33M100.00%38.51M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Chicago Pacific Founders42.30%1,406,88516,292
Leavitt Equity Partners10.71%356,2704,126

People Also Watch

1.50
CODX
-1.32%
1.23
CAST
-0.81%
2.70
BIYA
-2.88%
2.61
DXST
-2.25%

FAQ

What Is the P3 Health Partners (PIII) Stock Price Today?

The P3 Health Partners stock price today is 12.8300 USD.

What Stock Exchange Does P3 Health Partners Trade On?

P3 Health Partners is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for P3 Health Partners?

The stock symbol for P3 Health Partners is "PIII."

What Is the P3 Health Partners Market Cap?

As of today, P3 Health Partners market cap is 90.8900M USD.

What Is P3 Health Partners's Earnings Per Share (TTM)?

The P3 Health Partners EPS (TTM) is -38.5363.

When Is the Next P3 Health Partners Earnings Date?

P3 Health Partners will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is PIII a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has P3 Health Partners Stock Split?

P3 Health Partners has split 1 times.

How Many Employees Does P3 Health Partners Have?

P3 Health Partners has 320 employees.

What is the current trading status of P3 Health Partners (PIII)?

As of Aug 10, 2026, P3 Health Partners (PIII) is trading at a price of 12.8300 USD, with a previous close of 11.5800 USD. The stock has fluctuated within a day range of 11.7300 USD to 13.8192 USD, while its 52-week range spans from 1.5200 USD to 16.8900 USD.

What Is P3 Health Partners (PIII) Price Target According to Analysts?

The average 12-month price target for P3 Health Partners is 14.0000 USD, with a high estimate of 14 USD and a low estimate of 14 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +9.12% Upside potential.

What Is the PIII Premarket Price?

PIII's last pre-market stock price is 11.6600 USD. The pre-market share volume is 70.0000, and the stock has decreased by 0.0800, or 0.6900%.

What Is the PIII After Hours Price?

PIII's last after hours stock price is 16.2113 USD, the stock has decreased by 3.3813, or 26.3500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.